Hippocampal epilepsy produced by ouabain. Studies of cerebral circulation and ionic metabolism.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D002417:Cattle; D002540:Cerebral Cortex / Q000378:metabolism* / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects*; D008775:Methylprednisolone / Q000494:pharmacology; D010042:Ouabain; D010313:Partial Pressure; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000134:cerebrospinal fluid / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology; D012688:Septum Pellucidum / Q000378:metabolism / Q000503:physiopathology; D012895:Sleep, REM; D012964:Sodium / Q000134:cerebrospinal fluid / Q000378:metabolism; D014978:Xenon
D002245:Carbon Dioxide; D014978:Xenon; D010042:Ouabain; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D011188:Potassium; D008775:Methylprednisolone